-
1 Comment
GNI Group Ltd is currently in a long term downtrend where the price is trading 6.7% below its 200 day moving average.
From a valuation standpoint, the stock is 86.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.8.
GNI Group Ltd's total revenue rose by 33.5% to $3B since the same quarter in the previous year.
Its net income has increased by 905.3% to $791M since the same quarter in the previous year.
Finally, its free cash flow fell by 644.2% to $-37M since the same quarter in the previous year.
Based on the above factors, GNI Group Ltd gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Exchange | TSE |
| ISIN | JP3386370005 |
| CurrencyCode | JPY |
| Industry | Biotechnology |
| PE Ratio | 136.52 |
|---|---|
| Target Price | 1300 |
| Market Cap | 53B |
| Beta | 1.46 |
| Dividend Yield | 0.0% |
GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial phase II and pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, it is involved in developing F351, which is in Phase II clinical trial for the treatment of liver fibrosis; and F573 that is in pre-clinical phase for the treatment of acute on chronic liver failure, as well as Tamibarotene for the treatment of acute promyelocytic leukemia. GNI Group Ltd. was incorporated in 2001 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2160.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
